{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:31:21Z","timestamp":1782916281656,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T00:00:00Z","timestamp":1464393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["6614"],"award-info":[{"award-number":["6614"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-016-0626-2","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T12:48:44Z","timestamp":1464353324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial"],"prefix":"10.1186","volume":"14","author":[{"given":"Heather E.","family":"Tulloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Pipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl","family":"Els","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Clyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,28]]},"reference":[{"key":"626_CR1","volume-title":"The health consequences of smoking\u201450 years of progress: A Report of the Surgeon General","author":"US Department of Health and Human Services","year":"2014","unstructured":"US Department of Health and Human Services. The health consequences of smoking\u201450 years of progress: A Report of the Surgeon General. Atlanta: USDHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014."},{"key":"626_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2105\/AJPH.92.6.1002","volume":"92","author":"P Jha","year":"2002","unstructured":"Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health. 2002;92:1002\u20136.","journal-title":"Am J Public Health."},{"key":"626_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/tc.2009.032474","volume":"19","author":"CL Storr","year":"2010","unstructured":"Storr CL, Cheng H, Alonso J, et al. Smoking estimates from around the world: Data from the first 17 participating countries in the World Mental Health Survey Consortium. Tob Control. 2010;19:65\u201374.","journal-title":"Tob Control."},{"key":"626_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1360-0443.2011.03636.x","volume":"107","author":"R Borland","year":"2012","unstructured":"Borland R, Li L, Driezen P, et al. Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction. 2012;107:197\u2013205.","journal-title":"Addiction."},{"key":"626_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","volume":"99","author":"JR Hughes","year":"2004","unstructured":"Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29\u201338.","journal-title":"Addiction."},{"key":"626_CR6","first-page":"CD009329","volume":"5","author":"K Cahill","year":"2013","unstructured":"Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:CD009329.","journal-title":"Cochrane Database Syst Rev."},{"key":"626_CR7","volume-title":"Treating tobacco use and dependence: 2008 update: Clinical Practice Guideline","author":"M Fiore","year":"2008","unstructured":"Fiore M, Jaen C, Baker T. Treating tobacco use and dependence: 2008 update: Clinical Practice Guideline. Rockville: US Department of Health and Human Services, Public Health Service; 2008. Report No.: 1437906621."},{"key":"626_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/07853890.2012.705016","volume":"44","author":"EJ Mills","year":"2012","unstructured":"Mills EJ, Wu P, Lockhart I, Thorlund K, Puhan M, Ebbert JO. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis. Ann Med. 2012;44:588\u201397.","journal-title":"Ann Med."},{"key":"626_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/thx.2007.090647","volume":"63","author":"HJ Aubin","year":"2008","unstructured":"Aubin HJ, Bobak A, Britton JR, et al. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax. 2008;63:717\u201324.","journal-title":"Thorax."},{"key":"626_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/archgenpsychiatry.2009.142","volume":"66","author":"ME Piper","year":"2009","unstructured":"Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of five smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009;66:1253.","journal-title":"Arch Gen Psychiatry."},{"key":"626_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1253\/circj.CJ-09-0803","volume":"74","author":"H Tsukahara","year":"2010","unstructured":"Tsukahara H, Noda K, Saku K. A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study). Circ J. 2010;74:771.","journal-title":"Circ J."},{"issue":"4","key":"626_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2015.19284","volume":"315","author":"T Baker","year":"2016","unstructured":"Baker T, Piper M, Stein J, Smith S, Bolt D, Fraser D, et al. Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26\u00a0weeks: A randomized clinical trial. JAMA. 2016;315(4):371\u20139.","journal-title":"JAMA"},{"key":"626_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","volume":"121","author":"NA Rigotti","year":"2010","unstructured":"Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease a randomized trial. Circulation. 2010;121:221\u20139.","journal-title":"Circulation."},{"key":"626_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.addbeh.2011.07.002","volume":"36","author":"MB Steinberg","year":"2011","unstructured":"Steinberg MB, Randall J, Greenhaus S, Schmelzer AC, Richardson DL, Carson JL. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline. Addict Behav. 2011;36:1127\u201332.","journal-title":"Addict Behav."},{"key":"626_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1378\/chest.10-0865","volume":"139","author":"DP Tashkin","year":"2011","unstructured":"Tashkin DP, Rennard S, Hays JT, Ma W, Lawrence D, Lee TC. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest. 2011;139:591\u20139.","journal-title":"Chest."},{"key":"626_CR16","doi-asserted-by":"publisher","first-page":"e2856","DOI":"10.1136\/bmj.e2856","volume":"344","author":"JJ Prochaska","year":"2012","unstructured":"Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012;344:e2856.","journal-title":"BMJ."},{"key":"626_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.7326\/0003-4819-159-6-201309170-00005","volume":"159","author":"RM Anthenelli","year":"2013","unstructured":"Anthenelli RM, Morris C, Ramey TS, et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med. 2013;159:390\u2013400.","journal-title":"Ann Intern Med."},{"key":"626_CR18","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","volume":"68","author":"LE Hong","year":"2011","unstructured":"Hong LE, Thaker GK, McMahon RP, et al. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 2011;68:1195\u2013206.","journal-title":"Arch Gen Psychiatry."},{"key":"626_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jsat.2010.03.007","volume":"38","author":"JB McClure","year":"2010","unstructured":"McClure JB, Swan GE, Catz SL, et al. Smoking outcome by psychiatric history after behavioral and varenicline treatment. J Subst Abuse Treat. 2010;38:394\u2013402.","journal-title":"J Subst Abuse Treat."},{"key":"626_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.schres.2011.02.003","volume":"129","author":"E Weiner","year":"2011","unstructured":"Weiner E, Buchholz A, Coffay A, et al. Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study. Schizophr Res. 2011;129:94\u20135.","journal-title":"Schizophr Res."},{"key":"626_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4088\/JCP.11m07522","volume":"73","author":"JM Williams","year":"2012","unstructured":"Williams JM, Anthenelli RM, Morris CD, et al. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2012;73:654\u201360. doi: 10.4088\/JCP.11m07522 .","journal-title":"J Clin Psychiatry."},{"key":"626_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15504263.2012.671067","volume":"8","author":"BS Wu","year":"2012","unstructured":"Wu BS, Weinberger AH, Mancuso E, et al. A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder. J Dual Diagnosis. 2012;8:131\u20132.","journal-title":"J Dual Diagnosis."},{"key":"626_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cct.2014.05.011","volume":"38","author":"H Tulloch","year":"2014","unstructured":"Tulloch H, Pipe A, Els C, et al. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: Rationale, methods and participant characteristics of the FLEX trial. Contemp Clin Trials. 2014;38:304\u201313.","journal-title":"Contemp Clin Trials."},{"key":"626_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","volume":"43","author":"JR Hughes","year":"1986","unstructured":"Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43:289.","journal-title":"Arch Gen Psychiatry."},{"key":"626_CR25","doi-asserted-by":"crossref","unstructured":"Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G, The M.I.N.I. International Neuropsychiatric Interview (M.I.N.I.). The Development and Validation of a Structured Diagnostic Psychiatric Interview. J Clin Psychiatry. 1998;59(suppl 20):22\u201333.","DOI":"10.1037\/t18597-000"},{"key":"626_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O. The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119\u201327.","journal-title":"Br J Addict."},{"key":"626_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","volume":"100","author":"R West","year":"2005","unstructured":"West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100:299\u2013303.","journal-title":"Addiction."},{"key":"626_CR28","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/j.1360-0443.2007.01946.x","volume":"102","author":"D Hedeker","year":"2007","unstructured":"Hedeker D, Mermelstein RJ, Demirtas H. Analysis of binary outcomes with missing data: missing\u2009=\u2009smoking, last observation carried forward, and a little multiple imputation. Addiction. 2007;102:1564\u201373.","journal-title":"Addiction."},{"key":"626_CR29","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1176\/appi.ajp.2013.12121599","volume":"170","author":"RD Gibbons","year":"2013","unstructured":"Gibbons RD, Mann JJ. Varenicline, smoking cessation, and neuropsychiatric adverse events. Am J Psychiatry. 2013;170:1460\u20137.","journal-title":"Am J Psychiatry."},{"key":"626_CR30","doi-asserted-by":"publisher","first-page":"b3805","DOI":"10.1136\/bmj.b3805","volume":"339","author":"D Gunnell","year":"2009","unstructured":"Gunnell D, Irvine D, Wise L, Davies C, Martin RM. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ. 2009;339:b3805.","journal-title":"BMJ."},{"key":"626_CR31","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/add.12165","volume":"108","author":"B Pasternak","year":"2013","unstructured":"Pasternak B, Svanstr\u00f6m H, Hviid A. Use of varenicline versus bupropion and risk of psychiatric adverse events. Addiction. 2013;108:1336\u201343.","journal-title":"Addiction."},{"key":"626_CR32","doi-asserted-by":"publisher","first-page":"f5704","DOI":"10.1136\/bmj.f5704","volume":"347","author":"KH Thomas","year":"2013","unstructured":"Thomas KH, Martin RM, Davies NM, Metcalfe C, Windmeijer F, Gunnell D. Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study. BMJ. 2013;347:f5704.","journal-title":"BMJ."},{"key":"626_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jama.2015.280","volume":"313","author":"JO Ebbert","year":"2015","unstructured":"Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA. 2015;313:687\u201394.","journal-title":"JAMA."},{"key":"626_CR34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/ntr\/ntq103","volume":"12","author":"ML Costa","year":"2010","unstructured":"Costa ML, Cohen JE, Chaiton MO, Ip D, McDonald P, Ferrence R. \u201cHardcore\u201d definitions and their application to a population-based sample of smokers. Nicotine Tob Res. 2010;12:860\u20134.","journal-title":"Nicotine Tob Res."},{"key":"626_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/1462220021000060428","volume":"5","author":"KE Warner","year":"2003","unstructured":"Warner KE, Burns DM. Hardening and the hard-core smoker: concepts, evidence, and implications. Nic Tob Res. 2003;5:37\u201348.","journal-title":"Nic Tob Res."},{"key":"626_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1056\/NEJM199708213370806","volume":"337","author":"J LeLorier","year":"1997","unstructured":"LeLorier J, Gr\u00e9goire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. NEJM. 1997;337:536\u201342.","journal-title":"NEJM."},{"issue":"4","key":"626_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/jamainternmed.2014.8313","volume":"175","author":"R Schnoll","year":"2015","unstructured":"Schnoll R, Goelz P, Veluz-Wilkins A, Blazekovic S, Powers L, Leone F, et al. Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Int Med. 2015;175(4):504\u201311.","journal-title":"JAMA Int Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-016-0626-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0626-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T20:06:57Z","timestamp":1567973217000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-016-0626-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1186\/s12916-016-0626-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,28]]},"article-number":"80"}}